Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:52:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and removal of the generic government funding status notice (and the prior Revision: v3.4.1) appear to be administrative site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:06:37.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Site-wide notices about government funding and NIH Clinical Center operating status are displayed, and the page version has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:17:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary is now shown, update-history fields (Last Update Submitted that Met QC Criteria and Last Update Posted) are added, No FEAR Act Data is included, and the page revision is shown as v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T05:41:39.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page now adds Ovarian cancer as a related topic and includes MedlinePlus Genetics in related topics, a minor metadata update that does not affect study details or decisions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-21T04:52:03.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4; removed Ovarian cancer and MedlinePlus Genetics, along with Revision: v3.3.3 from the related topics.
    Difference
    0.2%
    Check dated 2026-01-14T03:12:09.000Z thumbnail image

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.